GRI Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -60%. Total operating expenses were $11,330,000.

Profit Margin

GRI Bio, Inc. (NASDAQ:GRI): Profit margin
2019 0 -3.46M
2020 100K -4.82M -4822%
2021 0 -1.50M
2022 0 -3.54M
2023 21.76M -13.03M -59.89%

GRI Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
21.76M00100K0
Cost of revenue
57K206K73K0735
Gross profit
21.71M-206K-73K100K-735
Operating exp.
Research and development
3.23M242K249K3.70M1.88M
Selling and marketing
2.95M0000
Total operating expenses
11.33M2.23M1.06M4.81M3.15M
Operating income
-11.38M-2.23M-1.06M-4.78M-3.15M
Other income (expenses), net
-1.65M-978K-497K-34K-310.07K
Income before tax
-13.03M-3.21M-1.55M-4.82M-3.46M
Income tax expense
2.76M325K-50K-131.29K5
Net income
-13.03M-3.54M-1.50M-4.82M-3.46M
Earnings per share
Basic EPS
-28.25-8.43-4.65-14.87-10.68
Diluted EPS
-28.25-8.43-4.65-14.87-10.68